Sunday, April 4, 2021

Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India

Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said in a statement to stock exchanges.

from Moneycontrol Business News https://ift.tt/3dy39mn

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...